Zanubritnib and Anti-MAG Neuropathy

Clinical trial NCT07392229 · RECRUITING

Trial details

NCT number: NCT07392229
Sponsor: Azienda Ospedaliera di Padova
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-MAG IgM-associated Demyelinating Polyneuropathy

Start date: 2026-03-24
Primary completion: 2031-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.